Patheon plans additional investment in Milton Park, UK unit

By Admin
Leading provider of contract development and commercial manufacturing services company Patheon Inc has planned to make additional investment in its Mil...

Leading provider of contract development and commercial manufacturing services company Patheon Inc has planned to make additional investment in its Milton Park facility. Patheon is a dedicated pharmaceutical development services facility focused on early development projects.

The company currently provides proof-of-concept and first –in man development programs for oral dose forms. It also offers Quick to Clinic which provides clinical trial materials as fast as four months from receipt of active pharmaceutical ingredient.

The service has been structured to provide support to emerging pharmaceutical companies’ with promising molecules. With the first phase of additional investment to Patheon’s Milton Park facility, the company will be able to  expand on the early development capabilities currently being offered, including the introduction of the SoluPath program.

The purchase of the new HME screening tool and spray-drier will supplement existing technologies at Milton Park to provide the SoluPath™ service to emerging pharmaceutical companies with poorly soluble molecules.

Robin Platt, Senior Director, Operations for Milton Park, said, “The introduction of Solupath™ into Milton Park’s existing capabilities is an exciting addition to Patheon’s service offering in Europe.” said Robin Platt, Senior Director, Operations for Milton Park.

Patheon Inc is a leading provider of contract development and commercial manufacturing services to the global pharmaceutical industry for a wide range of solid and sterile dosage forms. It provides highest quality products and services to 300 of the world’s leading pharmaceutical and biotechnology companies.

Share
Share

Featured Articles

WHO Health Chatbot Built on 'Humanised' GenAI

World Health Organisation's GenAI digital health tool is built using ‘AI humanisation’ tech & designed to ease burden on health workers & educate on health

Costco Weight-Loss Drugs Move Highlights US AOM Growth

Costco move to partner with online healthcare provider Sesame to provide members with weight-loss drugs including Wegovy signals US anti-obesity boom

AstraZeneca Company Profile, as CEO Soriot Lands pay Deal

As it's announced AstraZeneca's CEO Pascal Soriot's package could rise by as much as US$24mn we explore the history of the UK's most valuable business

US Academic Medical Centres 'Struggling' says McKinsey

Hospitals

J&J Community Initiatives Tackle US Healthcare Chasm

Medical Devices & Pharma

PitchBook: Healthcare Private Equity Deals see Decline

Health Insurance & Finance